Tapewire

Nasdaq · USD

OM

Outset Medical, Inc.

Export transactions ↓
Tapewire entity
7026
SEC CIK
0001484612
Parsed reports
379

Last 12 months

Inside the activity.

2 purchase rows · 23 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202501
Jan 202609
Feb 202603
Mar 202600
Apr 202600
May 202603
Jun 202601
Jul 202600
Aug 202603
Sep 202600
Oct 202620

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 11, 2022 Filed Nov 14, 2022 19:59 UTC
Vazquez MartinChief Operating Officer
SaleCommon Stock 370 $20.00 $7,400.00
Disclosure

SEC source: 0001484612-22-000071 · edgardoc.xml · nonDerivative · entry 8

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,550

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.

Read SEC document
November 11, 2022 Filed Nov 14, 2022 19:59 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionCommon Stock 370 $3.88 $1,435.60
Disclosure

SEC source: 0001484612-22-000071 · edgardoc.xml · nonDerivative · entry 7

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,920

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2022 Filed Nov 14, 2022 19:59 UTC
Vazquez MartinChief Operating Officer
SaleCommon Stock 4,630 $20.00 $92,600.00
Disclosure

SEC source: 0001484612-22-000071 · edgardoc.xml · nonDerivative · entry 6

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,550

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.

Read SEC document
November 11, 2022 Filed Nov 14, 2022 19:59 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionCommon Stock 4,630 $3.88 $17,964.40
Disclosure

SEC source: 0001484612-22-000071 · edgardoc.xml · nonDerivative · entry 5

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,180

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2022 Filed Nov 14, 2022 19:59 UTC
Vazquez MartinChief Operating Officer
SaleCommon Stock 5,000 $20.00 $100,000.00
Disclosure

SEC source: 0001484612-22-000071 · edgardoc.xml · nonDerivative · entry 4

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,550

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.

Read SEC document
November 11, 2022 Filed Nov 14, 2022 19:59 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionCommon Stock 5,000 $3.88 $19,400.00
Disclosure

SEC source: 0001484612-22-000071 · edgardoc.xml · nonDerivative · entry 3

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,550

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2022 Filed Nov 14, 2022 19:59 UTC
Vazquez MartinChief Operating Officer
SaleCommon Stock 5,000 $20.00 $100,000.00
Disclosure

SEC source: 0001484612-22-000071 · edgardoc.xml · nonDerivative · entry 2

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,550

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.

Read SEC document
November 11, 2022 Filed Nov 14, 2022 19:59 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionCommon Stock 5,000 $3.88 $19,400.00
Disclosure

SEC source: 0001484612-22-000071 · edgardoc.xml · nonDerivative · entry 1

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,550

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 573 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of March 1, 2022 to August 31, 2022. This transaction is exempt from Rule 16b-3(c).

Read SEC document
November 11, 2022 Filed Nov 15, 2022 00:53 UTC
Trigg LeslieDirector · Chair and CEO
Exercise / conversionPerformance Options (right to buy) · Derivative 30,000 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001484612-22-000070 · edgardoc.xml · derivative · entry 4

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,508

Underlying: Common Stock · 30,000 shares

Expires 2027-09-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Read SEC document
November 11, 2022 Filed Nov 15, 2022 00:53 UTC
Trigg LeslieDirector · Chair and CEO
SaleCommon Stock 30,000 $20.00 $600,000.00
Disclosure

SEC source: 0001484612-22-000070 · edgardoc.xml · nonDerivative · entry 2

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 291,159

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022.

Read SEC document
November 11, 2022 Filed Nov 15, 2022 00:53 UTC
Trigg LeslieDirector · Chair and CEO
Exercise / conversionCommon Stock 30,000 $3.88 $116,400.00
Disclosure

SEC source: 0001484612-22-000070 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 321,159

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 25, 2022 Filed Oct 26, 2022 21:18 UTC
Porter Stacey L.Chief People Officer
SaleCommon Stock 131 $15.02 $1,967.62
Disclosure

SEC source: 0001484612-22-000069 · edgardoc.xml · nonDerivative · entry 1

Porter Stacey L. · CIK 0001889204 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,564

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 374 shares of Common Stock underlying RSUs granted to the reporting person on October 22, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
September 01, 2022 Filed Sep 2, 2022 22:56 UTC
Ahmed NabeelChief Financial Officer
SaleCommon Stock 87 $18.05 $1,570.35
Disclosure

SEC source: 0001484612-22-000068 · edgardoc.xml · nonDerivative · entry 1

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,413

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 22, 2022.

F2 · shares: Includes 87 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of March 1, 2022 to August 31, 2022. This transaction is exempt from Rule 16b-3(c).

Read SEC document
August 16, 2022 Filed Aug 16, 2022 22:14 UTC
Brottem John L.General Counsel
SaleCommon Stock 351 $21.48 $7,539.48
Disclosure

SEC source: 0001484612-22-000063 · edgardoc.xml · nonDerivative · entry 1

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,314

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 698 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
August 16, 2022 Filed Aug 16, 2022 18:26 UTC
Vazquez MartinChief Operating Officer
SaleCommon Stock 260 $21.48 $5,584.80
Disclosure

SEC source: 0001484612-22-000067 · edgardoc.xml · nonDerivative · entry 1

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,977

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 516 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
August 16, 2022 Filed Aug 16, 2022 22:25 UTC
Trigg LeslieDirector · Chair and CEO
SaleCommon Stock 914 $21.48 $19,632.72
Disclosure

SEC source: 0001484612-22-000066 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 291,159

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,822 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
August 16, 2022 Filed Aug 16, 2022 22:17 UTC
Racine Jean-OlivierChief Technology Officer
SaleCommon Stock 292 $21.48 $6,272.16
Disclosure

SEC source: 0001484612-22-000065 · edgardoc.xml · nonDerivative · entry 1

Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,628

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,180 shares of Common Stock underlying RSUs granted to the reporting person on June 22, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
August 16, 2022 Filed Aug 16, 2022 22:16 UTC
Porter Stacey L.Chief People Officer
SaleCommon Stock 106 $21.48 $2,276.88
Disclosure

SEC source: 0001484612-22-000064 · edgardoc.xml · nonDerivative · entry 1

Porter Stacey L. · CIK 0001889204 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,695

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 299 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
August 16, 2022 Filed Aug 16, 2022 22:12 UTC
Ahmed NabeelChief Financial Officer
SaleCommon Stock 121 $21.48 $2,599.08
Disclosure

SEC source: 0001484612-22-000062 · edgardoc.xml · nonDerivative · entry 1

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,413

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 239 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
August 08, 2022 Filed Aug 9, 2022 20:01 UTC
Ahmed NabeelChief Financial Officer
SaleCommon Stock 1,048 $19.25 $20,174.00
Disclosure

SEC source: 0001484612-22-000061 · edgardoc.xml · nonDerivative · entry 1

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,534

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 2,099 shares of Common Stock underlying RSUs granted to the reporting person on August 5, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
August 01, 2022 Filed Aug 2, 2022 17:14 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionPerformance Options (right to buy) · Derivative 5,000 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001484612-22-000060 · edgardoc.xml · derivative · entry 6

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,007

Underlying: Common Stock · 5,000 shares

Expires 2027-12-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Read SEC document
August 01, 2022 Filed Aug 2, 2022 17:14 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionPerformance Options (right to buy) · Derivative 5,000 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001484612-22-000060 · edgardoc.xml · derivative · entry 5

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,007

Underlying: Common Stock · 5,000 shares

Expires 2027-12-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Read SEC document
August 01, 2022 Filed Aug 2, 2022 17:14 UTC
Vazquez MartinChief Operating Officer
SaleCommon Stock 5,000 $20.00 $100,000.00
Disclosure

SEC source: 0001484612-22-000060 · edgardoc.xml · nonDerivative · entry 4

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,237

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.

Read SEC document
August 01, 2022 Filed Aug 2, 2022 17:14 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionCommon Stock 5,000 $3.88 $19,400.00
Disclosure

SEC source: 0001484612-22-000060 · edgardoc.xml · nonDerivative · entry 3

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,237

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 01, 2022 Filed Aug 2, 2022 17:14 UTC
Vazquez MartinChief Operating Officer
SaleCommon Stock 5,000 $20.00 $100,000.00
Disclosure

SEC source: 0001484612-22-000060 · edgardoc.xml · nonDerivative · entry 2

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,237

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.

Read SEC document
August 01, 2022 Filed Aug 2, 2022 17:14 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionCommon Stock 5,000 $3.88 $19,400.00
Disclosure

SEC source: 0001484612-22-000060 · edgardoc.xml · nonDerivative · entry 1

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,237

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 01, 2022 Filed Aug 2, 2022 21:07 UTC
Trigg LeslieDirector · Chair and CEO
Exercise / conversionPerformance Options (right to buy) · Derivative 30,000 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001484612-22-000059 · edgardoc.xml · derivative · entry 4

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,508

Underlying: Common Stock · 30,000 shares

Expires 2027-09-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Read SEC document
August 01, 2022 Filed Aug 2, 2022 21:07 UTC
Trigg LeslieDirector · Chair and CEO
SaleCommon Stock 30,000 $20.00 $600,000.00
Disclosure

SEC source: 0001484612-22-000059 · edgardoc.xml · nonDerivative · entry 2

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,073

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022.

Read SEC document
August 01, 2022 Filed Aug 2, 2022 21:07 UTC
Trigg LeslieDirector · Chair and CEO
Exercise / conversionCommon Stock 30,000 $3.88 $116,400.00
Disclosure

SEC source: 0001484612-22-000059 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 322,073

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 19, 2022 Filed Jul 19, 2022 23:02 UTC
Ahmed NabeelChief Financial Officer
SaleCommon Stock 787 $16.56 $13,032.72
Disclosure

SEC source: 0001484612-22-000058 · edgardoc.xml · nonDerivative · entry 1

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,582

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,575 shares of Common Stock underlying RSUs granted to the reporting person on July 16, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
June 23, 2022 Filed Jun 24, 2022 21:33 UTC
Racine Jean-OlivierChief Technology Officer
SaleCommon Stock 1,157 $14.50 $16,776.50
Disclosure

SEC source: 0001484612-22-000057 · edgardoc.xml · nonDerivative · entry 1

Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,920

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 4,719 shares of Common Stock underlying RSUs granted to the reporting person on June 22, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Includes 500 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2021 to February 28, 2022. This transaction is exempt from Rule 16b-3(c).

Read SEC document
June 01, 2022 Filed Jun 2, 2022 16:30 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionPerformance Options (right to buy) · Derivative 5,000 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001484612-22-000054 · edgardoc.xml · derivative · entry 3

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,007

Underlying: Common Stock · 5,000 shares

Expires 2027-12-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Read SEC document
June 01, 2022 Filed Jun 2, 2022 16:30 UTC
Vazquez MartinChief Operating Officer
SaleCommon Stock 5,000 $21.42 $107,081.50
Disclosure

SEC source: 0001484612-22-000054 · edgardoc.xml · nonDerivative · entry 2

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,237

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $20.00-$21.99 - 509 shares; $21.00-$22.99 - 4,286 shares; $23.00-$23.99 - 205 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 01, 2022 Filed Jun 2, 2022 16:30 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionCommon Stock 5,000 $3.88 $19,400.00
Disclosure

SEC source: 0001484612-22-000054 · edgardoc.xml · nonDerivative · entry 1

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,237

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 01, 2022 Filed Jun 2, 2022 20:30 UTC
Trigg LeslieDirector · Chair and CEO
Exercise / conversionPerformance Options (right to buy) · Derivative 14,289 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001484612-22-000055 · edgardoc.xml · derivative · entry 7

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,508

Underlying: Common Stock · 14,289 shares

Expires 2027-09-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Read SEC document
June 01, 2022 Filed Jun 2, 2022 20:30 UTC
Trigg LeslieDirector · Chair and CEO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 15,711 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001484612-22-000055 · edgardoc.xml · derivative · entry 6

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,711 shares

Expires 2027-09-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option vested in 48 equal monthly installments beginning on October 19, 2017.

Read SEC document
June 01, 2022 Filed Jun 2, 2022 20:30 UTC
Trigg LeslieDirector · Chair and CEO
SaleCommon Stock 15,711 $20.95 $329,093.60
Disclosure

SEC source: 0001484612-22-000055 · edgardoc.xml · nonDerivative · entry 4

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,073

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2,2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $20.00-$21.99 - 17,954 shares; $21.00-$22.99 - 11,446 shares; $23.00-$23.99 - 600 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 01, 2022 Filed Jun 2, 2022 20:30 UTC
Trigg LeslieDirector · Chair and CEO
Exercise / conversionCommon Stock 15,711 $3.88 $60,958.68
Disclosure

SEC source: 0001484612-22-000055 · edgardoc.xml · nonDerivative · entry 3

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,784

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 01, 2022 Filed Jun 2, 2022 20:30 UTC
Trigg LeslieDirector · Chair and CEO
SaleCommon Stock 14,289 $20.95 $299,307.40
Disclosure

SEC source: 0001484612-22-000055 · edgardoc.xml · nonDerivative · entry 2

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,073

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2,2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $20.00-$21.99 - 17,954 shares; $21.00-$22.99 - 11,446 shares; $23.00-$23.99 - 600 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 01, 2022 Filed Jun 2, 2022 20:30 UTC
Trigg LeslieDirector · Chair and CEO
Exercise / conversionCommon Stock 14,289 $3.88 $55,441.32
Disclosure

SEC source: 0001484612-22-000055 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 306,362

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 31, 2022 Filed Jun 1, 2022 21:20 UTC GrantCommon Stock 6,880 $0.00 $0.00
Disclosure

SEC source: 0001484612-22-000053 · edgardoc.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,551

F1 · kind: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Read SEC document
May 31, 2022 Filed Jun 1, 2022 20:36 UTC GrantCommon Stock 6,880 $0.00 $0.00
Disclosure

SEC source: 0001484612-22-000051 · edgardoc.xml · nonDerivative · entry 1

Saia Andrea Lynn · CIK 0001552993 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,211

F1 · kind: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Read SEC document
May 31, 2022 Filed Jun 1, 2022 20:26 UTC
JONES DALE EDirector
GrantCommon Stock 6,880 $0.00 $0.00
Disclosure

SEC source: 0001484612-22-000049 · edgardoc.xml · nonDerivative · entry 1

JONES DALE E · CIK 0001261562 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,237

F1 · kind: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Read SEC document
May 31, 2022 Filed Jun 1, 2022 20:25 UTC GrantCommon Stock 6,880 $0.00 $0.00
Disclosure

SEC source: 0001484612-22-000048 · edgardoc.xml · nonDerivative · entry 1

Szyman Catherine M. · CIK 0001438538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,915

F1 · kind: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Read SEC document
May 31, 2022 Filed Jun 1, 2022 20:24 UTC GrantCommon Stock 6,880 $0.00 $0.00
Disclosure

SEC source: 0001484612-22-000047 · edgardoc.xml · nonDerivative · entry 1

Hinrichs James F. · CIK 0001506974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,168

F1 · kind: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Read SEC document
May 31, 2022 Filed Jun 1, 2022 20:23 UTC GrantCommon Stock 6,880 $0.00 $0.00
Disclosure

SEC source: 0001484612-22-000046 · edgardoc.xml · nonDerivative · entry 1

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,168

F1 · kind: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Read SEC document
May 31, 2022 Filed Jun 1, 2022 20:21 UTC GrantCommon Stock 6,880 $0.00 $0.00
Disclosure

SEC source: 0001484612-22-000045 · edgardoc.xml · nonDerivative · entry 1

GROSSMAN D KEITH · CIK 0001218702 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,168

F1 · kind: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Read SEC document
May 17, 2022 Filed May 17, 2022 22:59 UTC
Brottem John L.General Counsel
SaleCommon Stock 349 $26.36 $9,199.64
Disclosure

SEC source: 0001484612-22-000038 · edgardoc.xml · nonDerivative · entry 1

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,665

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 699 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
May 17, 2022 Filed May 17, 2022 19:04 UTC
Vazquez MartinChief Operating Officer
SaleCommon Stock 258 $26.36 $6,800.88
Disclosure

SEC source: 0001484612-22-000042 · edgardoc.xml · nonDerivative · entry 1

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,237

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 516 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
May 17, 2022 Filed May 17, 2022 23:03 UTC
Trigg LeslieDirector · Chair and CEO
SaleCommon Stock 909 $26.36 $23,961.24
Disclosure

SEC source: 0001484612-22-000041 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,073

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,821 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.